Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help enable the unhindered movement of medicinal drugs from EU countries into the UK after the end of the transition period.
Our priority is to ensure that patients continue to have access to the medicines they need. We continue to work closely with industry, the National Health Service and others in the supply chain to deliver the shared goal of continuity of safe patient care by mitigating any potential disruption to supply into the United Kingdom of medicines at the end of the transition period.
As set out in a letter from the Department to industry of 3 August, we are implementing a multi-layered approach, that involves asking suppliers of medicines and medical products to the UK from or via the European Union to get trader ready, reroute their supply chains away from any potential disruption and stockpile to a target level of six weeks on UK soil where this is possible. The letter is available at the following link: